Mandate

VINGE ADVISES HEXATRONIC IN CONJUNCTION WITH RIGHTS ISSUE AND OVERSUBSCRIPTION OPTION

March 02, 2015

Vinge has advised Hexatronic Group AB (publ) listed on NASDAQ Stockholm First North in conjunction with a rights issue of approximately SEK 41 million with an oversubscription option of approximately SEK 10 million, which may be exercised if the rights issue is oversubscribed. One subscription right is provided for each share in Hexatronic and six subscription rights entitle the holder to subscribe for one new share. The subscription price amounts to SEK 9 per share. It is estimated that the rights issue prospectus will be published on or about 14 April 2015.

Vinge’s team consisted of responsible partner Anders Strid together with associates Frida Bäckegren, Daniel Lennartsson and corporate assistant Camilla Andersson.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025